본문 바로가기
bar_progress

Text Size

Close

[e Gongsi Notice Catches Attention] KOSDAQ - 18th


◆Genexine=Completion of Phase 1/2a clinical trial for COVID-19 vaccine (GX-19)


◆Joycity=Change to sole CEO system with CEO Jo Sung-won


◆TCK=Change to co-CEO system with Masafumi Tsuji and Hiroshi Takahashi


◆Tuksu Construction=Signed construction contract worth 19.9 billion KRW with SK Construction


◆Corentec=Acquired patent rights for tibial osteotomy guide assembly


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top